Skip to content

Prognostic value of thyroid peroxidase antibody and other clinicopathological factors in lymph node metastasis of thyroid cancer

Prognostic value of thyroid peroxidase antibody and other clinicopathological factors in lymph node metastasis of thyroid cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081987
Enrollment
Unknown
Registered
2024-03-18
Start date
2023-12-01
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid carcinoma

Interventions

Observation group:None

Sponsors

Guangzhou First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18-75 years old. 2. Surgical method: resection of at least the glandular lobe and isthmus, accompanied by central lymph node dissection (CLND). 3. The postoperative pathology was papillary thyroid carcinoma with or without Hashimoto's thyroiditis.

Exclusion criteria

Exclusion criteria: 1. Previous history of thyroid surgery or disease recurrence; 2. Previous history of exposure to radiation in the head and neck region; 3, lack of preoperative TPOAb results or not Guangzhou First People's Hospital TPOAb results; 4, thyroid follicular cancer, medullary cancer or undifferentiated thyroid cancer; 5. Patients with incomplete medical records.

Design outcomes

Primary

MeasureTime frame
Positive predictive value;Negative predictive value;

Secondary

MeasureTime frame
sensitivity;specificity;

Countries

China

Contacts

Public ContactHuang Xindong

Guangzhou First People's Hospital

1326556495@qq.com+86 138 2253 4344

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026